Based in the United States, Imvaria is a startup.
Imvaria develops AI-driven digital biomarker software-as-medical-device solutions to enable non-invasive, accurate diagnosis and prognosis of lung diseases such as idiopathic pulmonary fibrosis, helping clinicians make earlier and more precise clinical decisions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.